We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Anti-Inflammatory Drugs May Block Bicarbonate Transport

By Biotechdaily staff writers
Posted on 21 Dec 2004
Researchers have found that some carbonic anhydrase inhibitors--including such clinically used anti-inflammatory drugs as celecoxib--will inhibit bicarbonate transport at clinically significant concentrations, which may help to explain the basis for some of the side effects experienced by those taking the drug.

Investigators at the University of Alberta (Edmonton, Canada; www.ualberta.ca) genetically engineered a variant of the HEK293 cell line to express the human erythrocyte membrane Cl−/HCO3− exchanger, AE1. More...
They then examined the effect of 16 different carbonic anhydrase inhibitors on AE1 transport activity. Among these, 12 were newly reported compounds, two were clinically used nonsteroidal anti-inflammatory drugs (celecoxib and valdecoxib), and two were anticonvulsant drugs (topiramate and zonisamide). The investigators measured transport by following changes of intracellular [Cl−] and pH, using intracellular fluorescent reporter dyes.

Results published in the November 23, 2004, issue of Molecular Membrane Biology revealed that celecoxib and four of the novel compounds significantly inhibited AE1 Cl−/NO3− exchange activity, and that bulkier compounds had greater AE1 inhibitory potency.




Related Links:
University of Alberta

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
STI Test
Vivalytic MG, MH, UP/UU
New
Repetitive Pipette
VWR® Stepper Pro
New
Steam Sterilizer
Hi Vac II Line
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.